Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

KORU Medical Systems (KRMD) Cost of Revenue (2020 - 2025)

KORU Medical Systems has reported Cost of Revenue over the past 11 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $4.1 million for Q4 2025, up 24.49% from a year ago — trailing twelve months through Dec 2025 was $15.5 million (up 26.06% YoY), and the annual figure for FY2025 was $15.5 million, up 26.06%.
  • Cost of Revenue for Q4 2025 was $4.1 million at KORU Medical Systems, down from $4.1 million in the prior quarter.
  • Over the last five years, Cost of Revenue for KRMD hit a ceiling of $4.1 million in Q3 2025 and a floor of $2.2 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $3.1 million (2023), compared with a mean of $3.1 million.
  • Biggest five-year swings in Cost of Revenue: soared 51.07% in 2021 and later dropped 22.6% in 2023.
  • KORU Medical Systems' Cost of Revenue stood at $2.7 million in 2021, then increased by 22.86% to $3.3 million in 2022, then fell by 12.6% to $2.9 million in 2023, then grew by 14.74% to $3.3 million in 2024, then increased by 24.49% to $4.1 million in 2025.
  • The last three reported values for Cost of Revenue were $4.1 million (Q4 2025), $4.1 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.